Vision and quality of life: Development of methods for the VisQoL vision-related utility instrument

Ophthalmic Epidemiology

Volumn 15, Issue 4, 2008, Pages 218-223

  Peacock, Stuart ^a,b,f   Misajon, RoseAnne ^c   Iezzi, Angelo ^c   Richardson, Jeff ^c   Hawthorne, Graeme ^d   Keeffe, Jill ^d,e  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f Cancer Control Research   (Canada)

Author keywords

Cost utility analysis; Economic evaluation; Time trade off; Utility instrument; Vision related quality of life

Indexed keywords

ARTICLE; ECONOMIC EVALUATION; EYE CARE; HEALTH STATUS; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; VISION; VISQOL DESCRIPTIVE SYSTEM;

COST-BENEFIT ANALYSIS; HUMANS; MODELS, THEORETICAL; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; VISION; VISION DISORDERS; VISUAL ACUITY; VISUALLY IMPAIRED PERSONS;

EID: 51549115494     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580801979417     Document Type: Article

References (27)

1. Eye Research Australia, Access Economics. Clear Insight: The Economic Impact and Cost of Vision Loss in Australia. Melbourne: Access Economics, 2004.
2. Taylor HR, McCarty CA, Nanjan MB. Vision impairment predicts five-year mortality. Trans Am Ophthalmol Soc. 2000;98:91-6.
3. Weih LM, Hassell JB, Keeffe JE. Assessment of the impact of vision impairment. Invest Ophthalmol Vis Sci. 2002;43:927-35
4. Wang JJ, Mitchell P, Smith W, et al. Incidence of nursing home placement in a defined community. Med J Aust. 2001;174:271-5.
5. Wang JJ, Mitchell P, Smith W, et al. Factors associated with use of community support services in an older Australian population. Aust & NZ J Pub Health. 1999;23:147-53.
6. West SK, Munoz B, Rubin GS, et al. Function and visual impairment in a population-based study of older adults. Invest Ophthalmol Vis Sci. 1997;38:72-82.
7. McCarty CA, Fu CL, Taylor HR. Predictors of falls in the Melbourne Visual Impairment Project. Aust NZ J Public Health. 2002;26:11611-9.
8. Rovner BW, Casten RJ, Tasman WS. Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol. 2002;120:1041-4.
9. Misajon R, Hawthorne G, Richardson J, Barton J, Peacock S, Iezzi A, Keeffe J. Vision and quality of life: The development of a utility measure. Invest Ophthalmol Vis Sci. 2005;46:4007-15.
10. Hawthorne G, Richardson J, Osborne R. The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res. 1999;8(3):209-24.
11. Richardson J, Day N, Peacock S, Iezzi A. Measurement of quality of life for economic evaluation and the Assessment of Quality of Life (AQoL) Mark II instrument. Australian Economic Review. 2004;37:62-88.
12. EuroQol Group. EuroQol: A new facility for measurement of health-related quality of life. Health Pol. 1990;16:199-208.
13. Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M. Multi-attribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40(2):113-28.
14. Lee JE, Fos PJ, Zuniga MA, Kastl PR, Sung JH. Assessing health-related quality of life in cataract patients: The relationship between utility and health-related quality of life measurement. Qual Life Res. 2001;9:1127-35.
15. Brenner MH, Curbow B, Legro MW. The proximal-distal continuum of multiple health outcomes measures - the case of cataract-surgery. Med Care. 1995;33:236-44.
16. Hawthorne G, Richardson J, Osborne R, McNeil H. The Assessment of Quality of Life (AQoL) instrument: Construction, initial validation & utility scaling, Working Paper 76. Melbourne, Australia: Centre for Health Program Evaluation, Monash University, 1997.
17. Cronbach J, Meehl P. Construct validity in Psychological tests, Psychological Bull. 1955;52:281-302.
18. Torrance G. Measurement of health state utilities for economic appraisal: A review, J Health Econ. 1986;5:1-30.
19. Richardson J. Economic assessment of health care: Theory in practice. Australian Econ. Rev. 1991;1:4-21.
20. Richardson J. Cost utility analysis: What should be measured? Soc Sci Med. 1994;39:7-21.
21. Richardson J, Hawthorne G. Negative utility scores and evaluating the AQoL all worst health state, Working Paper 113. Melbourne, Australia: Centre for Health Program Evaluation, Monash University, 2001.
22. Ubel PA, Loewenstein G, Hershey J, Baron J, Mohr T, Asch DA, Jepson C. Do non patients underestimate the quality of life associated with chronic health conditions because of a focusing illusion? Med Decision Making. 2001;21:190-199.
23. Richardson J, Peacock S, Day NA, Hawthorne G, Iezzi A. The Assessment of Quality of Life (AQoL) 2 Instrument: Derivation of the scaling weights using a multiplicative model and econometric second stage correction, Working Paper 142. Melbourne, Australia: Health Economics Unit, Monash University, 2004.
24. von Winterfeldt D, Edwards W. Decision Analysis and Behavioural Research. Cambridge, Cambridge University Press, 1986.
25. Furlong W, Feeny D, Torrance G, Goldsmith C, Depauw S, Zhu Z, Denton M, Boyle M. Multiplicative Multi-Attribute Utility Function for the Health Utilities Index Mark 3 (HUI3) System: A Technical Report, Working Paper 98-11. Hamilton, Ontario, Canada: McMaster University, Centre for Health Economics and Policy Analysis, 1998.
26. Furlong W, Feeny D, Torrance G, Barr R. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001;33:375-384.
27. Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol. 1998;51:1115-1128.